Early Effectiveness Assessed for Fourth Dose of BNT162b2 Vaccine
Difference in absolute risk for three versus four doses was 180.1 and 68.8 cases per 100,000 for COVID-19-related hospitalization, severe COVID-19
Geriatric Illnesses
US Life Expectancy Dropped Between 2019 and 2020
Decrease larger in Hispanic, non-Hispanic Black versus non-Hispanic White population; decrease larger than in peer countries
Pet Meds Listed in Owner’s Medication Profile Lead to Confusion in the ED
The patient, a 67-year-old female, presented to the emergency department with altered mental status.
Medicare Expands Telemedicine Coverage During COVID-19 Pandemic
Expansion will allow millions of seniors to take care of medical problems while staying at home
Ryanodex NDA Resubmitted for Exertional Heat Stroke
In July 2017, Eagle had received a Complete Response Letter (CRL) from the FDA stating that an additional clinical trial would be needed prior to approval for the indication.
Preventive Drugs Often Used in Last Year of a Cancer Patient’s Life
Preventive drugs, including antihypertensives and statins, frequently continued until final month of life
Long-Term Systemic Hormone Therapy May Up Alzheimer Risk
Risk increases associated with hormone therapy exposure over 10 years in women <60 years at initiation
Recombinant Zoster Vaccine Cost-Effective in Simulation
Incremental cost-effectiveness ratio varied from $10,000 to $47,000 per QALY for RZV versus no vaccine
AGS: Beers Criteria for Potentially Inappropriate Med Use in Older Adults Updated
Over 1400 clinical trials and research studies were reviewed by a panel of 13 experts to develop the new guideline.
